Table 3 Operative details and anticoagulation treatment during and after flap surgery
Flap# | Patient# | Type | Arterial | Venous | Intraop. anticoagulation | Postop. anticoagulation |
|---|---|---|---|---|---|---|
1A | 1.1 | DIEP | IMA | 1 × CV | 500 IU | 15,000 IU/24 h |
2A | 1.2 | DIEP | IMA | 1 × CV | 500 IU | 15,000 IU/24 h |
3A | 2.1 | DIEP | IMA | 1 × CV | 500 IU | 15,000 IU/24 h |
4A | 3.1 | LD/PSC | AR | 1 × CV | 1000 IU | 2 × 0.6 Enoxaparin |
5A | 4.1 | VRAM | PA via GSV | 1 × CV | 500 IU Bolus/300 IU/h | 20,000 IU/24 h/ASS 100 mg |
6A | 5.1 | DIEP | IMA | 1 × CV | 500 IU Bolus/300 IU/h | 2 × 0.4 Enoxaparin |
7A | 6.1 | ALT | PTA | 1 × GSV | 500 IU | 15,000 IU/24 h |
8A | 7.1 | Gracilis | PTA | 2 × CV | 500 IU | 2 × 0.3 Enoxaparin |
9A | 7.2 | LD | PTA | 1 × CV | 500 IU | 2 × 0.6 Enoxaparin |
10A | 7.3 | VRAM | Two stage—AVL | 500 IU Bolus/300 IU/h | 25,000 IU/24 h | |
11A | 8.1 | DIEP | IMA | 1 × CV | 500 IU | 20,000 IU/24 h |
12A | 9.3 | LD | PTA | 1 × CV | 2000 IU | 20,000 IU/24 h |
13A | 14.2 | LD | ATA | 1 × CV | 500 IU | 2 × 0.3 Enoxaparin |
14A | 15.2 | LD | ATA | 1 × CV | 1000 IU | 25,000 IU/24 h/100 mg ASS |
1B | 9.1 | LD | One stage—AVL | 1000 IU | 20,000 IU/24 h/Arixtra 2.5 mg | |
2B | 9.2 | Gracilis | PTA | 1 × CV | 500 IU | 2 × 0.3 Enoxaparin |
3B | 10.1 | LD | PTA | 2 × CV | 500 IU Bolus/300 IU/h/500 mg ASS | 15,000 IU/24 h |
4B | 11.1 | ALT | PTA | 1 × GSV/1 × CV | 500 IU | 2 × 0.4 Enoxaparin |
5B | 12.1 | PSC | Two stage—AVL | 1000 IU | 2 × 0.4 Enoxaparin | |
6B | 13.1 | DIEP | IMA | 1 × CV | 500 IU | 2 × 0.3 Enoxaparin |
7B | 13.2 | DIEP | IMA | 1 × CV | 500 IU | 2 × 0.3 Enoxaparin |
8B | 14.1 | ALT | ATA | 1 × CV | 500 IU | 15,000 IU/24 h |
9B | 15.1 | LD | PTA via GSV | 1 × CV | 500 IU | 15,000 IU/24 h |